{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Richmond",
      "state": "VA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "BLA761043"
        ],
        "brand_name": [
          "BENLYSTA"
        ],
        "generic_name": [
          "BELIMUMAB"
        ],
        "manufacturer_name": [
          "GlaxoSmithKline LLC"
        ],
        "product_ndc": [
          "49401-088",
          "49401-102",
          "49401-101"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "BELIMUMAB"
        ],
        "rxcui": [
          "1656395",
          "1656398",
          "1656400",
          "1656402",
          "1939296",
          "1939299",
          "1939346",
          "1939348"
        ],
        "spl_id": [
          "379d7f58-8f17-44b3-8336-6fe8ef015aed"
        ],
        "spl_set_id": [
          "2fa3c528-1777-4628-8a55-a69dae2381a3"
        ],
        "package_ndc": [
          "49401-102-01",
          "49401-101-01",
          "49401-088-42",
          "49401-088-47",
          "49401-088-50",
          "49401-088-01",
          "49401-088-35",
          "49401-088-02",
          "49401-088-61"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000182156",
          "N0000182637",
          "N0000182636"
        ],
        "pharm_class_pe": [
          "Decreased B Lymphocyte Activation [PE]"
        ],
        "pharm_class_epc": [
          "B Lymphocyte Stimulator-specific Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "B Lymphocyte Stimulator-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "73B0K5S26A"
        ]
      },
      "product_type": "Drugs",
      "event_id": "97110",
      "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office",
      "address_1": "9954 Maryland Drive",
      "address_2": "Deep Run Iii Ste. 4000",
      "postal_code": "23233",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Within the U.S - OH, VA, FL.",
      "recall_number": "D-0540-2025",
      "product_description": "BENLYSTA  (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.",
      "product_quantity": "3 Vials",
      "reason_for_recall": "CGMP Deviations; potential temperature excursions due to transit delays",
      "recall_initiation_date": "20250421",
      "center_classification_date": "20250721",
      "report_date": "20250730",
      "code_info": "Lot: YK4W, Expiration date: 4/30/2029"
    }
  ]
}